![Xinhua Zhao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xinhua Zhao
Career history of Xinhua Zhao
Former positions of Xinhua Zhao
Companies | Position | Start | End |
---|---|---|---|
TERRAVIA HOLDINGS INC | Chief Tech/Sci/R&D Officer | 13/05/2012 | - |
Corporate Officer/Principal | 28/02/2010 | 13/05/2012 | |
AureoGen, Inc.
![]() AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Private Equity Analyst | - | 03/02/2010 |
Corporate Officer/Principal | 03/02/2010 | - |
Training of Xinhua Zhao
Purdue University | Doctorate Degree |
Zhejiang University | Graduate Degree |
Statistics
International
United States | 4 |
China | 2 |
Operational
Corporate Officer/Principal | 2 |
Private Equity Analyst | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
TerraVia Holdings, Inc.
![]() TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables TerraVia Holdings, Inc. engaged in the production of food, nutrition, and specialty ingredients from algae. It produced oils, specialty fats, and powdered ingredients using its microalgae-based technology platform. The company was founded by Jonathan S. Wolfson and Harrison F. Dillon on March 31, 2003 and was headquartered in San Francisco, CA. | Consumer Non-Durables |
AureoGen, Inc.
![]() AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Health Technology |
- Stock Market
- Insiders
- Xinhua Zhao
- Experience